Hap Trading, LLC Veru Inc. Call Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	SELL	$1.16 - $6.41 $78,648 - $434,598	-67,800 Reduced 81.98%	14,900 $1,000
Q4 2022 Feb 14, 2023	BUY	$4.78 - $15.01 $209,842 - $658,939	43,900 Added 113.14%	82,700 $6,000
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $66,430 - $154,050	6,500 Added 20.12%	38,800 $146,000
Q2 2022 Aug 12, 2022	SELL	$4.35 - $15.85 $58,724 - $213,975	-13,500 Reduced 29.48%	32,300 $117,000
Q1 2022 May 12, 2022	BUY	$4.55 - $6.41 $151,970 - $214,094	33,400 Added 269.35%	45,800 $23,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $110,732 - $182,924	-18,800 Reduced 60.26%	12,400 $2,000
Q3 2021 Nov 10, 2021	BUY	$6.78 - $9.89 $115,260 - $168,130	17,000 Added 119.72%	31,200 $6,000
Q2 2021 Aug 11, 2021	BUY	$7.24 - $11.2 $102,808 - $159,040	14,200 New	14,200 $5,000
Q1 2021 May 14, 2021	SELL	$8.05 - $20.78 $104,650 - $270,140	-13,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.36 - $9.99 $30,680 - $129,870	13,000 New	13,000 $18,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.